Literature DB >> 28114675

Interventions for Female Pattern Hair Loss.

Esther J van Zuuren1, Zbys Fedorowicz2.   

Abstract

Clinical Question: Which interventions are effective and safe for treating female pattern hair loss (FPHL)? Bottom Line: There was low- to moderate-quality evidence that topical minoxidil (2% and 5%) was associated with improvements in FPHL. There was low-quality evidence that finasteride was no more effective than placebo. There were inconsistent results from studies that laser devices were effective, but total hair count increased compared with baseline (moderate- to low-quality evidence). Most treatments were not associated with higher adverse event rates than placebo.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28114675     DOI: 10.1001/jamadermatol.2016.5790

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  5 in total

Review 1.  Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.

Authors:  Raquel N Rozner; Azael Freites-Martinez; Jerry Shapiro; Eliza B Geer; Shari Goldfarb; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2018-11-22       Impact factor: 4.872

Review 2.  Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.

Authors:  Mark S Nestor; Glynis Ablon; Anita Gade; Haowei Han; Daniel L Fischer
Journal:  J Cosmet Dermatol       Date:  2021-11-06       Impact factor: 2.189

3.  Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: A Randomized Controlled Trial.

Authors:  Mansour Siavash; Fereshteh Tavakoli; Fatemeh Mokhtari
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

Review 4.  Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review.

Authors:  Kornelia Pietrauszka; Beata Bergler-Czop
Journal:  Postepy Dermatol Alergol       Date:  2020-10-16       Impact factor: 1.664

5.  Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial.

Authors:  Xuelei Liang; Yuan Chang; Haixuan Wu; Yi Liu; Jian Zhao; Leyi Wang; Fenglin Zhuo
Journal:  Front Med (Lausanne)       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.